World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25980
World Ranking
17927
National Ranking
8943

Paul F. Engstrom publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul F. Engstrom sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 274 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul F. Engstrom D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul F. Engstrom sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul F. Engstrom is affiliated with Fox Chase Cancer Center in the United States. Their research primarily focuses on areas within the field of Medicine, with particular emphasis on Epidemiology, Neurology, and Oncology.

The scientist's work contributes to topics such as:

  • Neuroendocrine Tumor Research Advances
  • Neuroblastoma Research and Treatments
  • Lung Cancer Research Studies

Paul F. Engstrom has published research in journals including:

  • British Journal of Cancer
  • Cancer Immunology Immunotherapy

Their notable recent papers include:

  • "Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials" published in 2020 in the British Journal of Cancer
  • "Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms" published in 2021 in Cancer Immunology Immunotherapy

Frequent co-authors collaborating with Paul F. Engstrom include:

  • Namrata Vijayvergia
  • Arvind Dasari
  • R. Katherine Alpaugh
  • Mengying Deng
  • Samuel Litwin

The scientist's research is closely linked to clinical and immune-related aspects of cancer treatment, focusing on high-grade neuroendocrine neoplasms and immunotherapy interventions.

Best Publications

  • Prognostic effect of weight loss prior tochemotherapy in cancer patients

    William D. Dewys;Colin Begg;Philip T. Lavin;Pierre R. Band

  • Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

    Al B. Benson;Alan P. Venook;Lynette Cederquist;Emily Chan

  • NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • Rectal cancer, version 2.2018 clinical practice guidelines in Oncology

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • NCCN Clinical Practice Guidelines in Oncology: colon cancer.

    Engstrom Pf;Arnoletti Jp;Benson Ab rd;Chen Yj

  • Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

    D J Klaassen;J M MacIntyre;G E Catton;P F Engstrom

  • Factors associated with repeat adherence to breast cancer screening

    Caryn Lerman;Barbara Rimer;Bruce Trock;Andrew Balshem

  • Psychological and Behavioral Implications of Abnormal Mammograms

    Caryn Lerman;Bruce Trock;Barbara K. Rimer;Alice Boyce

  • NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

    Engstrom Pf;Arnoletti Jp;Benson Ab rd;Chen Yj

  • Mammography Adherence and Psychological Distress Among Women at Risk for Breast Cancer

    Caryn Lerman;Mary Daly;Colleen Sands;Andrew Balshem

  • Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

    Corey J. Langer;John C. Leighton;Robert L. Comis;Peter J. O'Dwyer

  • Neuroendocrine tumors, version 1.2015

    Matthew H. Kulke;Manisha H. Shah;Al B. Benson;Emily Bergsland

  • NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

    Clark Oh;Benson Ab rd;Berlin Jd;Choti Ma

  • Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma

    Lawrence R. Coia;Paul F. Engstrom;Anthony R. Paul;Patrick M. Stafford

  • Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.

    Paul F. Engstrom;Philip T. Lavin;Charles G. Moertel;Eckert Folsch

  • Why women resist screening mammography: patient-related barriers.

    B K Rimer;M K Keintz;H B Kessler;P F Engstrom

  • Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.

    E. R. Sauter;E. Ross;M. Daly;A. Klein-Szanto

  • Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

    Gary J. Kelloff;Scott M. Lippman;Andrew J. Dannenberg;Caroline C. Sigman

  • Screening mammography: A missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies

    Paul F. Engstrom;Bruce Trock;Barbara Rimer;Andrew Balshem

  • Chemoprevention of cancer.

    Christine E. Szarka;Generosa Grana;Paul F. Engstrom

Frequent Co-Authors

Barbara K. Rimer
Barbara K. Rimer University of North Carolina at Chapel Hill
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
John M. Skibber
John M. Skibber The University of Texas MD Anderson Cancer Center
Al B. Benson
Al B. Benson Northwestern University
Alan P. Venook
Alan P. Venook University of California, San Francisco
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Mary F. Mulcahy
Mary F. Mulcahy Northwestern University
Christopher G. Willett
Christopher G. Willett Duke University
Michael A. Choti
Michael A. Choti The University of Texas Southwestern Medical Center
Caryn Lerman
Caryn Lerman University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but considering a related field or a flexible career path? There are a variety of online degrees that prepare students for impactful roles in healthcare outside of becoming a physician.

For those interested in healthcare leadership and operations, healthcare administration degree programs offer a fast-track into management roles. These programs can be completed online, allowing students to balance studies with other commitments.

Nurses looking to advance their careers might consider asn to nurse practitioner programs. These bridge programs enable registered nurses with an associate degree to earn a Master of Science in Nursing, opening doors to new clinical specializations.

Another growing area is nutrition and wellness. Accredited online nutrition degree programs provide the foundational knowledge for roles in dietetics, public health, and preventative care.

Those seeking top leadership positions can explore top cahme-accredited mha programs. These online MHA degrees are respected in the industry and focus on developing the expertise needed for executive healthcare roles.

Exploring these online educational pathways can open up diverse, rewarding careers in the dynamic healthcare sector.

Best Scientists Citing Paul F. Engstrom

Trending Scientists

Recently Published Articles